Information:
Error:
ID
43950
Description
A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.; ODM derived from: https://clinicaltrials.gov/show/NCT00517699
Link
https://clinicaltrials.gov/show/NCT00517699
Keywords
Versions (3)
- 6/29/17 6/29/17 -
- 7/3/17 7/3/17 - Julian Varghese
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphoma NCT00517699
Eligibility Lymphoma NCT00517699
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00517699
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
adult patients, 18-80 years of age;
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
histological diagnosis of primary central nervous system lymphoma;
boolean
C0280803 (UMLS CUI [1])
ID.3
Item
b-cell proliferation verified by positive staining for cd20;
boolean
C1155008 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C3888518 (UMLS CUI [1,2])
ID.4
Item
>=1 measurable lesion.
boolean
C0221198 (UMLS CUI [1])
ID.5
Item
prior chemotherapy, other than corticosteroids, >=6 weeks before and after diagnosis or surgery;
boolean
C0392920 (UMLS CUI [1])
ID.6
Item
history of prior cranial irradiation;
boolean
C0079172 (UMLS CUI [1])
non hodgkin lymphoma
Item
evidence of plurisystemic non-hodgkin's lymphoma;
boolean
C0024305 (UMLS CUI [1])
ID.8
Item
other active malignant disease (other than basal cell or squamous cell cancer of skin,or cancer in situ of cervix;
boolean
C0012634 (UMLS CUI [1])
ID.9
Item
uncontrolled active infection.
boolean
C3714514 (UMLS CUI [1])